Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Return on Assets [ROA] (2021 - 2026)

Updated

Global Innovative Platforms (GIPL) recorded Return on Assets [ROA] of -119.70% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 178.16 percentage points from -297.86% a year earlier and up 38.76 percentage points from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Global Innovative Platforms reported Return on Assets [ROA] of -720.81%, up 62626.63 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a three-year change of -496.67 percentage points (FY2022 to FY2025).
  • Across earlier fiscal years, Return on Assets [ROA] came in at -63347.44% in FY2024 (-62173.37 pp), -1174.07% in FY2023 (-949.92 pp) and -224.14% in FY2022.
  • The fiscal Q3 2026 figure is the highest quarterly Return on Assets [ROA] in data going back to fiscal Q4 2021.
  • On a year-over-year basis, Return on Assets [ROA] rose in seven of the last eight quarters, with an average year-over-year change of +14313.00 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 70202.19 percentage points in fiscal Q4 2024, against a drop of 72658.85 percentage points in fiscal Q4 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -158.46% (Q2 2026), -305.13% (Q1 2026) and -351.71% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - -119.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -119.70%
Mar 31, 2026 -158.46%
Dec 31, 2025 -305.13%
Sep 30, 2025 -351.71%
Jun 30, 2025 -297.86%
Mar 31, 2025 -224.90%
Dec 31, 2024 -279.10%
Sep 30, 2024 -2,680.80%
Jun 30, 2024 -3,422.38%
Mar 31, 2024 -15,791.85%
Dec 31, 2023 -23,341.81%
Sep 30, 2023 -72,882.99%
Jun 30, 2023 -11,697.17%
Mar 31, 2023 -588.59%
Dec 31, 2022 -239.77%
Sep 30, 2022 -224.14%
Jun 30, 2022 -15,224.81%
Mar 31, 2022 -15,458.40%
Dec 31, 2021 -20,454.20%
Sep 30, 2021 -781.08%
API Access

Global Innovative Platforms Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GIPL&period=max&api_key=YOUR_API_KEY